Published in Proc Natl Acad Sci U S A on July 01, 1982
Pancreatic islet transplantation--experimental experience and clinical potential. West J Med (1985) 0.75
Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med (1979) 8.32
A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes. J Exp Med (1976) 6.11
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med (1981) 5.00
Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol (1978) 4.55
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
The regulation of lymphocyte functions by the macrophage. Immunol Rev (1978) 2.43
Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor. J Exp Med (1980) 2.41
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum. Proc Natl Acad Sci U S A (1977) 1.93
Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A (1981) 1.77
Characterization of resident glomerular cells in the rat expressing Ia determinants and manifesting genetically restricted interactions with lymphocytes. J Clin Invest (1981) 1.72
Immunoassayable insulin content of subcellular fractions of rat islets. Endocrinology (1969) 1.57
Langerhans cells: a review of their nature with emphasis on their immunologic functions. Prog Allergy (1978) 1.37
Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex. Proc Natl Acad Sci U S A (1977) 1.36
Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens. J Exp Med (1980) 1.23
Induction of rejection of successful allografts of rat islets by donor peritoneal exudate cells. Transplantation (1979) 1.22
Prolongation of islet xenograft survival without continuous immunosuppression. Science (1980) 1.18
Reversal diabetes by islet transplantation: vulnerability of the established allograft. Science (1981) 1.10
Active suppression in the maintenance of pancreatic islet allografts. Transplantation (1981) 1.01
Effect of idiotype-specific suppressor T cells on primary and secondary responses. J Exp Med (1978) 0.98
Localization of MHC antigens in long surviving rat renal allografts: probable implication of passenger leukocytes in graft adaptation. Transplant Proc (1981) 0.98
Neonatal tolerance of H-2 alloantigens. I. I region modulation of tolerance potential of K and D antigens. Proc R Soc Lond B Biol Sci (1980) 0.94
Unique T cell Ia antigen expressed on a hybrid cell line producing antigen-specific augmenting T cell factor. J Immunol (1981) 0.88
Regulation of the immune response to tumor antigen. VIII. The effects of host specific anti-I-J antibodies on the immune response to tumors of different origin. Cell Immunol (1980) 0.85
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med (1981) 6.45
Serological identification of an Ir-region product. Science (1973) 3.32
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14
Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A (1981) 1.77
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Production of anti-H-2 antibodies in thymectomized mice. Eur J Immunol (1974) 1.74
Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association. Cancer (1972) 1.57
Production of monoclonal murine antibodies to DNA by somatic cell hybrids. Arthritis Rheum (1980) 1.56
Foot-and-mouth disease in man. Br Med J (1967) 1.54
Gastrointestinal presentation of Langerhans cell histiocytosis in a child with perianal skin tags: a case report. J Pediatr Gastroenterol Nutr (2004) 1.50
NOD mice are defective in proteasome production and activation of NF-kappaB. Mol Cell Biol (1999) 1.41
Ia antigens: their serology, molecular relationships, and their role in allograft reactions. Transplant Rev (1976) 1.28
Tolerance mechanism in experimental ovarian and gastric autoimmune diseases. J Immunol (1992) 1.27
Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens. J Exp Med (1980) 1.23
Human islet transplantation in patients with type I diabetes. Transplant Proc (1989) 1.22
The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones. Am J Otol (2000) 1.12
Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci. J Exp Med (1976) 1.11
Molecular relationship between private and public H-2 antigens as determined by antigen redistribution method. J Exp Med (1975) 1.11
Histocompatibility antigens controlled by the I region of the murine H-2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity. J Exp Med (1977) 1.08
Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest (1984) 1.07
Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. J Biol Chem (2000) 1.06
Induction of resistance to antibody-mediated cytotoxicity. H-2, Ia, and Ig antigens are independent entities in the membrane of mouse lymphocytes. J Exp Med (1975) 1.02
A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils. Allergy (2006) 1.02
Identification of interleukin-2 in human peripheral blood eosinophils. Immunology (1996) 0.99
Immunogenetic analysis of H-2 mutations. III. Genetic mapping and involvement in immune reactions of the H-2ka mutation. J Immunol (1975) 0.99
Effects of cytochalasins B and D on alloxan inhibition of insulin release. Biochem Biophys Res Commun (1975) 0.97
Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood (1995) 0.96
The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol (1997) 0.94
Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann N Y Acad Sci (1998) 0.92
Serological distinction of mutants B6.CH(zl) and B6.M505 from strain C57BL-6. J Exp Med (1974) 0.92
Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells. Diabetes (1986) 0.90
Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy (2013) 0.88
Ia and H-2 antigens on blast cells. Transplantation (1975) 0.88
Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse). Transplantation (1987) 0.88
Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells. Science (1982) 0.87
Inhibition of nonspecific binding of fluorescent-labelled antibodies to human eosinophils. J Immunol Methods (1998) 0.87
Monoclonal antibodies to mouse MHC antigens. I. Serologic characterization of ten anti-H-2 and anti-Ia reagents. Immunogenetics (1984) 0.87
Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. Proc Natl Acad Sci U S A (1994) 0.86
Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation (1993) 0.86
The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol (2000) 0.86
The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes (1986) 0.85
Tumor necrosis factor enhances interferon-induced Ia antigen expression on murine islet parenchymal cells. Am J Pathol (1988) 0.84
Response. Science (1992) 0.84
Cowbone Ridge virus, a new group B arbovirus from South Florida. Am J Epidemiol (1969) 0.84
Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood-derived CD34 progenitors. J Allergy Clin Immunol (2000) 0.84
Induction of class II MHC antigens on human and rodent islet parenchymal cells in vitro. Diabetologia (1987) 0.83
Streptozotocin-induced liver tumors. Transplantation (1977) 0.83
Identification of premature ovarian failure patients with underlying autoimmunity. J Womens Health Gend Based Med (2000) 0.82
Defective function of the proteasome in autoimmunity: involvement of impaired NF-kappaB activation. Diabetes Technol Ther (2000) 0.81
Regulation of pancreatic islet-cell plasma membrane Ca2+ + Mg2+-ATPase by calmodulin. FEBS Lett (1982) 0.81
Transplantation without immunosuppression. Diabetes (1982) 0.80
Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors. Immunology (2000) 0.80
Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices. Contraception (1998) 0.80
Large scale isolation, function, and transplantation of islets of Langerhans from the adult pig pancreas. Transplant Proc (1991) 0.80
Molecular mechanisms in eosinophil activation. Chem Immunol (2000) 0.80
Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics. Immunology (2000) 0.79
New concepts in effector functions of eosinophil cytokines. Clin Exp Allergy (2000) 0.79
Exocytotic events in eosinophils and mast cells. Clin Exp Allergy (1999) 0.79
Environmental pathobiology--the combined approach to problem solving and manpower training. Am J Pathol (1971) 0.78
Large plunging ranula with no intraoral component: a rare clinical entity. Ir Med J (2005) 0.78
Differences in expression of MHC products between several H-2-restricted CTL clones. J Immunol (1982) 0.78
Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site. Diabetes (1991) 0.78
Novel splicing of the human MHC-encoded peptide transporter confers unique properties. J Immunol (1999) 0.78
Murine anti-alpha (1 to 3) dextran antibody production by hybrid cells. Curr Top Microbiol Immunol (1978) 0.78
Evaluation of TAP1 polymorphisms with insulin dependent diabetes mellitus in Finnish diabetic patients. The Childhood Diabetes in Finland (DiMe) Study Group. Hum Immunol (1997) 0.78
The evolutionary origin of the HLA-DR3 haplotype. Immunogenetics (1992) 0.77
Induction of Ia antigen expression on murine islet parenchymal cells does not diminish islet allograft survival. Am J Pathol (1989) 0.77
Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts. Neurology (1993) 0.76
A role for NF-kappaB and the proteasome in autoimmunity. Arch Immunol Ther Exp (Warsz) (2000) 0.76
Dopamine agonists and pathological gambling. Parkinsonism Relat Disord (2006) 0.76
Continued mapping of chromosome 2 genes. Immunogenetics (1994) 0.76
Optimization of Babesia bovis transfection methods. Parassitologia (2007) 0.76
Survival of heart allografts in nonimmunosuppressed murine recipients by pretreatment of the donor tissue with anti-Ia antibodies. Transplantation (1982) 0.75
Family cell lines available for research--an endangered resource? Am J Hum Genet (1997) 0.75
Ultraviolet B irradiation reduces the surface expression of conformationally correct class I and II histocompatibility antigens. Transplant Proc (1997) 0.75
Monoclonal antibodies to mouse antigens. II. Characterization of thirty-one anti-I-J reagents. Immunogenetics (1985) 0.75
Splitting of antigen H-2.9 and mapping of its genetic determinants. Tissue Antigens (1975) 0.75
New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease. Diabetes (1997) 0.75
Trends in voice rehabilitation in the United Kingdom. Folia Phoniatr Logop (1995) 0.75
Oral contraceptives and venous thromboembolism. Lancet (1995) 0.75
Prolonged survival of donor skin grafts on mice bearing established islet of Langerhans transplants. Transplantation (1985) 0.75
A new histogenetic method for minor histocompatability antigen typing. J Immunol (1977) 0.75
Target-cell recognition by cloned lines of influenza virus-specific cytotoxic T lymphocytes. Selective inhibition by a monoclonal H-2-specific antibody. Immunogenetics (1982) 0.75
Human TAP1 polymorphisms detected by denaturing gradient gel electrophoresis. Tissue Antigens (1997) 0.75
Effects of a zinc deficient diet upon fluid intake in the rat. J Nutr (1977) 0.75
On the periphery: Nature questions the role of women in science. J Womens Health Gend Based Med (1999) 0.75
The role of the proteasome in autoimmunity. Diabetes Metab Res Rev (2000) 0.75
Mycotic abortion in the pig. Vet Rec (1985) 0.75
Automated purification of canine islets. Transplant Proc (1992) 0.75
Studies on recombination within the mouse H-2 complex: IV. Characterization of new recombinant haplotypes H-2t7, H-2t8, H-2as2, and H-2as3. J Mol Cell Immunol (1988) 0.75
A method for detection of Ia antigens in the absence of appropriate H-2 recombinants. J Immunol (1975) 0.75
Continued insulin dependence despite normal insulin sensitivity and graft insulin secretion in a kidney/islet transplant patient. Transplant Proc (1994) 0.75
Immunogenetic analysis of H-2 mutations. IV. Mapping of and immune reactions to the H-2fa mutation. Scand J Immunol (1976) 0.75